about
Endothelin-converting enzymes and related metalloproteases in Alzheimer's diseaseNeuroprotective natural antibodies to assemblies of amyloidogenic peptides decrease with normal aging and advancing Alzheimer's disease.Effect of Kidney Dysfunction on Cerebral Cortical Thinning in Elderly Population.Alzheimer's disease: relevant molecular and physiopathological events affecting amyloid-β brain balance and the putative role of PPARs.Global cPILOT analysis of the APP/PS-1 mouse liver proteome.Amyloid β levels in human red blood cellsTowards a whole-body systems [multi-organ] lipidomics in Alzheimer's disease.APOE genotype results in differential effects on the peripheral clearance of amyloid-beta42 in APOE knock-in and knock-out mice.Obesity and Hepatic Steatosis Are Associated with Elevated Serum Amyloid Beta in Metabolically Stressed APPswe/PS1dE9 MiceAmyloid-β induces hepatic insulin resistance by activating JAK2/STAT3/SOCS-1 signaling pathway.Physiological amyloid-beta clearance in the periphery and its therapeutic potential for Alzheimer's diseaseLow-density lipoprotein receptor overexpression enhances the rate of brain-to-blood Aβ clearance in a mouse model of β-amyloidosis.Protease inhibitors as potential disease-modifying therapeutics for Alzheimer's disease.Amyloid-β induces hepatic insulin resistance in vivo via JAK2.Brain-Wide Insulin Resistance, Tau Phosphorylation Changes, and Hippocampal Neprilysin and Amyloid-β Alterations in a Monkey Model of Type 1 Diabetes.Antibodies to potato virus Y bind the amyloid beta peptide: immunohistochemical and NMR studiesBiomarkers of Alzheimer Disease in Children with Obstructive Sleep Apnea: Effect of AdenotonsillectomyPlasma amyloid beta measurements - a desired but elusive Alzheimer's disease biomarkerAmyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease.Blood-brain barrier dysfunction as a cause and consequence of Alzheimer's disease.The role of metabolic disorders in Alzheimer disease and vascular dementia: two roads convergedIn vivo Differential Brain Clearance and Catabolism of Monomeric and Oligomeric Alzheimer's Aβ proteinDeglycosylated anti-Abeta antibody dose-response effects on pathology and memory in APP transgenic mice.Tauroursodeoxycholic acid prevents E22Q Alzheimer's Abeta toxicity in human cerebral endothelial cells.Depletion of vitamin E increases amyloid beta accumulation by decreasing its clearances from brain and blood in a mouse model of Alzheimer disease.The role of lipoprotein receptors on the physiological function of APP.Targeting ApoE4/ApoE receptor LRP1 in Alzheimer's disease.Is abeta a sufficient biomarker for monitoring anti-abeta clinical studies? A critical review.CR1 in Alzheimer's disease.Effects of prolonged angiotensin-converting enzyme inhibitor treatment on amyloid beta-protein metabolism in mouse models of Alzheimer disease.Metabolite Clearance During Wakefulness and Sleep.Exercise for the diabetic brain: how physical training may help prevent dementia and Alzheimer's disease in T2DM patients.Role of LRP1 in the pathogenesis of Alzheimer's disease: evidence from clinical and preclinical studies.Effects of ageing and experimental diabetes on insulin-degrading enzyme expression in male rat tissues.Lipopolysaccharide impairs amyloid β efflux from brain: altered vascular sequestration, cerebrospinal fluid reabsorption, peripheral clearance and transporter function at the blood-brain barrierPartial Loss of the Glutamate Transporter GLT-1 Alters Brain Akt and Insulin Signaling in a Mouse Model of Alzheimer's Disease.Dutch and Arctic mutant peptides of beta amyloid(1-40) differentially affect the FGF-2 pathway in brain endothelium.A Translational Systems Pharmacology Model for Aβ Kinetics in Mouse, Monkey, and Human.Peripheral amyloid-beta levels regulate amyloid-beta clearance from the central nervous system.Potential therapeutic system for Alzheimer's disease: removal of blood Aβs by hemodialzyers and its effect on the cognitive functions of renal-failure patients.
P2860
Q26862901-12F3807B-5557-41F5-A803-714497ED816EQ30489052-72128F00-F3D1-40A1-A004-8663E3E4B667Q33725864-DED55FD1-E6FA-4518-B4EF-862AA7BCA928Q33959032-5F2FC9D3-C8C6-4D2C-A323-64C35EB91F28Q34459615-E6E96B5C-E94E-406C-995E-0A6500F79457Q34482602-6B3578F1-84DF-4D9D-9A37-A6BDE8F75636Q35179546-090F1039-368B-4830-823E-5C212C78544CQ35799854-E0A3FA14-E198-4B2E-8E14-E4CE456212E0Q35921128-B335CE58-9123-4BF6-BCBE-7993A07EA0F7Q35976702-3D9D7A42-AF84-439D-9BBA-FAFC9CA105A4Q36073671-8C576FDC-B7C2-423E-83C6-D3F2F2AA9EA4Q36279902-26FDE481-64E1-4CAB-862D-4B8E1A80D90DQ36300032-8E49DD06-8C0F-4D50-86A5-76E19B99B473Q36720621-68E432FB-B82D-4744-87B4-782A197B08A8Q36792589-B8695DB9-0F73-47D9-B72A-A5AB086826E9Q36825498-240EAE84-639E-466C-B1C8-82D7FC3122EDQ36890114-84CC319E-64FB-4886-95A9-8363CE4B309AQ36998414-48CCFC5F-26B1-4FD6-A7FD-16BF385786A0Q37145570-775A7CB3-3782-4DFB-8BAB-3F7C0F01A46DQ37216153-9B993D92-415E-42B2-8E02-43D11D28B993Q37280580-C9FC8C2D-2DFF-4F42-A8B2-F665D378B30BQ37284771-7FCB237C-8FF8-46BD-9830-F443EFCFC4D1Q37353658-0132AFBD-10AD-4EA2-88A0-4402E0E97F1CQ37384925-953DBB7F-6795-4231-BB4C-C9F885F9C11EQ37446178-373D387D-13F0-4FCA-A17C-6436FBC153C1Q37938682-FC8AEFCC-4746-4944-B449-7D6926B2918FQ38097859-42C0ABF8-FC33-4E71-9841-C8D4FD55AC40Q38121070-6E8E81F6-4F83-4EA0-A38A-790B92E3D21DQ38209191-E63C9896-FECD-4886-9BBB-2CF77992FC45Q38306848-0174B732-A4F1-4A83-A37F-A5B34701EA83Q38661159-DB5B6F40-327A-43BA-B5FD-7722B6DAFE4BQ38830118-588F106F-A3F7-4682-916A-A9204E438BF2Q39222720-F70A4BD0-D0E6-4F3B-B4E9-DE3379450D6EQ41190059-7CEB247D-A7E7-4BF5-A642-C15DAFE8D33FQ42259826-A28AA651-C926-40DF-8EB6-AD39C50D3CEAQ42540801-062F3C04-5D60-4364-86C8-7A5B1FC3C0D7Q42586903-18C2892F-C21E-49A5-8215-D829F2E1C984Q42621620-6F1F8002-EDE3-4A9A-AFD2-FAA27F8E9BE6Q42703052-A38F6A8A-C4A6-4A8E-A169-34CA25AB6F1CQ44058569-9D9ED1FB-1C93-4015-A56D-A99601338468
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Systemic catabolism of Alzheimer's Abeta40 and Abeta42.
@ast
Systemic catabolism of Alzheimer's Abeta40 and Abeta42.
@en
type
label
Systemic catabolism of Alzheimer's Abeta40 and Abeta42.
@ast
Systemic catabolism of Alzheimer's Abeta40 and Abeta42.
@en
altLabel
Systemic Catabolism of Alzheimer's Aβ40 and Aβ42
@en
prefLabel
Systemic catabolism of Alzheimer's Abeta40 and Abeta42.
@ast
Systemic catabolism of Alzheimer's Abeta40 and Abeta42.
@en
P2093
P2860
P356
P1476
Systemic catabolism of Alzheimer's Abeta40 and Abeta42.
@en
P2093
Agueda Rostagno
Blas Frangione
Douglas Ng
Jorge Ghiso
Marcos Shayo
Samuel Gandy
Yasushi Tomidokoro
P2860
P304
45897-45908
P356
10.1074/JBC.M407668200
P407
P577
2004-08-20T00:00:00Z